Serine protease specificity for peptide chromogenic substrates
- PMID: 146272
Serine protease specificity for peptide chromogenic substrates
Abstract
Rates of hydrolysis of the newly developed peptide chromogenic substrates S-2160 (N-Bz-Phe-Val-Arg-pNA, HCl), S-2238 (H-D-Phe-Pip-Arg-pNA, 2HCl), S-2222 (N-Bz-Ile-Glu-Gly-Arg-pNA, HCl), and S-2251 (H-D-Val-Leu-Lys-pNA, 2HCl) from AB Kabi Peptide Research and Chromozym TH (Z-Gly-Pro-Arg-pNA, HCl) from Pentapharm Limited were tested against highly purified preparations of human plasmin, bovine trypsin, human alpha thrombin, and bovine factor Xa. S-2160, S-2238, and Chromozym TH are sensitive to thrombin, Chromozym TH and S-2238 exhibiting a substantially greater sensitivity than S-2160. All 3 substrates are insensitive to factor Xa but hydrolyzed to varying degrees by plasmin and trypsin. In contrast, S-2222 is sensitive to Xa and insensitive to thrombin. S-2251 is relatively plasmin-specific, being resistant to the clotting enzymes thrombin and Xa. S-2251 exhibits even greater sensitivity to the SK-plasmin complex than to plasmin. In addition, the substrate Chromozym PK (N-Bz-Pro-Phe-Arg-pNA, HCl) was evaluated and found to be relatively specific for plasma kallikrein. Assays for antithrombin III and heparin using S-2222 as the substrate and factor Xa as the enzyme, plasma plasminogen and plasmin inhibitors using S-2251 as the substrate, and plasma prekallikrein and kallikrein inhibitors using Chromozym PK as the substrate have been developed. Synthetic peptides mimicking amino acid sequences adjacent to proteolytic activation cleavage of plasma serine protease precursors appear to be sensitive and relatively specific tools applicable to kinetical and clinical studies of these enzymes and their inhibitors.
Similar articles
-
Sensitivity and specificity of plasma serine protease chromogenic substrates.Haemostasis. 1978;7(2-3):98-104. doi: 10.1159/000214244. Haemostasis. 1978. PMID: 149051
-
[Use of chromogenic substrates for estimation of indicators of kallikrein-kinin and blood coagulation systems in blood plasma of patients with nephrotic syndrome].Vopr Med Khim. 1983 Sep-Oct;29(5):96-9. Vopr Med Khim. 1983. PMID: 6557709 Russian.
-
Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates.Thromb Haemost. 1979 Oct 31;42(3):1039-45. Thromb Haemost. 1979. PMID: 159513
-
Synthetic peptide substrates in hemostatic testing.Crit Rev Clin Lab Sci. 1983;19(2):71-134. doi: 10.3109/10408368309165760. Crit Rev Clin Lab Sci. 1983. PMID: 6373139 Review.
-
Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system.Blood Coagul Fibrinolysis. 1994 Jun;5(3):411-36. Blood Coagul Fibrinolysis. 1994. PMID: 8075312 Review.
Cited by
-
Production and release of plasminogen by isolated perfused rat liver.Proc Natl Acad Sci U S A. 1980 Nov;77(11):6837-40. doi: 10.1073/pnas.77.11.6837. Proc Natl Acad Sci U S A. 1980. PMID: 6935686 Free PMC article.
-
The Kunitz-Type Protein ShPI-1 Inhibits Serine Proteases and Voltage-Gated Potassium Channels.Toxins (Basel). 2016 Apr 13;8(4):110. doi: 10.3390/toxins8040110. Toxins (Basel). 2016. PMID: 27089366 Free PMC article.
-
Protease-activated "prodrugs" for cancer chemotherapy.Proc Natl Acad Sci U S A. 1980 Apr;77(4):2224-8. doi: 10.1073/pnas.77.4.2224. Proc Natl Acad Sci U S A. 1980. PMID: 6246527 Free PMC article.
-
Kallikrein-like activity of crotalase, a snake venom enzyme that clots fibrinogen.Proc Natl Acad Sci U S A. 1982 Mar;79(6):1688-92. doi: 10.1073/pnas.79.6.1688. Proc Natl Acad Sci U S A. 1982. PMID: 7043462 Free PMC article.
-
Characterization of a novel intracellular endopeptidase of the alpha/beta hydrolase family from Streptomyces coelicolor A3(2).J Bacteriol. 2003 Jan;185(2):496-503. doi: 10.1128/JB.185.2.496-503.2003. J Bacteriol. 2003. PMID: 12511496 Free PMC article.